317 related articles for article (PubMed ID: 29865239)
1. Role of O-Acetylation in the Immunogenicity of Bacterial Polysaccharide Vaccines.
Berti F; De Ricco R; Rappuoli R
Molecules; 2018 Jun; 23(6):. PubMed ID: 29865239
[TBL] [Abstract][Full Text] [Related]
2. Bacterial polysaccharides as vaccines--immunity and chemical characterization.
Lee CJ; Lee LH; Lu CS; Wu A
Adv Exp Med Biol; 2001; 491():453-71. PubMed ID: 14533815
[TBL] [Abstract][Full Text] [Related]
3. Polyosides (encapsulated bacteria).
Lindberg AA
C R Acad Sci III; 1999 Nov; 322(11):925-32. PubMed ID: 10646085
[TBL] [Abstract][Full Text] [Related]
4. Preclinical studies on new proteins as carrier for glycoconjugate vaccines.
Tontini M; Romano MR; Proietti D; Balducci E; Micoli F; Balocchi C; Santini L; Masignani V; Berti F; Costantino P
Vaccine; 2016 Jul; 34(35):4235-4242. PubMed ID: 27317455
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate-Based Vaccines: An Overview.
Hütter J; Lepenies B
Methods Mol Biol; 2015; 1331():1-10. PubMed ID: 26169731
[TBL] [Abstract][Full Text] [Related]
6. Conjugated polysaccharide vaccines.
Ahmad H; Chapnick EK
Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.
Tacket CO; Ferreccio C; Robbins JB; Tsai CM; Schulz D; Cadoz M; Goudeau A; Levine MM
J Infect Dis; 1986 Aug; 154(2):342-5. PubMed ID: 2425009
[No Abstract] [Full Text] [Related]
8. Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation.
Fusco PC; Farley EK; Huang CH; Moore S; Michon F
Clin Vaccine Immunol; 2007 May; 14(5):577-84. PubMed ID: 17376859
[TBL] [Abstract][Full Text] [Related]
9. Experience with Salmonella typhi Vi capsular polysaccharide vaccine.
Hessel L; Debois H; Fletcher M; Dumas R
Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):609-20. PubMed ID: 10534182
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay.
de Voer RM; Schepp RM; Versteegh FG; van der Klis FR; Berbers GA
Clin Vaccine Immunol; 2009 Mar; 16(3):433-6. PubMed ID: 19129470
[TBL] [Abstract][Full Text] [Related]
11. [Conjugated vaccines].
Fritzell B
Therapie; 2005; 60(3):249-55. PubMed ID: 16128267
[TBL] [Abstract][Full Text] [Related]
12. Meningococcal disease: a review on available vaccines and vaccines in development.
Bröker M; Fantoni S
Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
[TBL] [Abstract][Full Text] [Related]
13. Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal Models.
Micoli F; Alfini R; Di Benedetto R; Necchi F; Schiavo F; Mancini F; Carducci M; Oldrini D; Pitirollo O; Gasperini G; Balocchi C; Bechi N; Brunelli B; Piccioli D; Adamo R
Front Immunol; 2021; 12():719315. PubMed ID: 34594333
[TBL] [Abstract][Full Text] [Related]
14. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
[TBL] [Abstract][Full Text] [Related]
15. Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidis.
Cripps AW; Foxwell R; Kyd J
Curr Opin Immunol; 2002 Oct; 14(5):553-7. PubMed ID: 12183152
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
[TBL] [Abstract][Full Text] [Related]
17. A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies.
Ozdilek A; Huang J; Babb R; Paschall AV; Middleton DR; Duke JA; Pirofski LA; Mousa JJ; Avci FY
mBio; 2021 Jun; 12(3):e0080021. PubMed ID: 34061603
[TBL] [Abstract][Full Text] [Related]
18. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
[TBL] [Abstract][Full Text] [Related]
19. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs.
Berti F; Micoli F
Curr Opin Immunol; 2020 Aug; 65():42-49. PubMed ID: 32361591
[TBL] [Abstract][Full Text] [Related]
20. NMR assays for carbohydrate-based vaccines.
Jones C
J Pharm Biomed Anal; 2005 Aug; 38(5):840-50. PubMed ID: 16087046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
